Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
Special Dividend Data
The current last sale of $3.05 is 1.33% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 3.229||$ 9.88|
|Low:||$ 3.01||$ 3.01|
Company Description (as filed with the SEC)
VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies to address unmet medical needs in human health. We have two approved therapies and one product candidate in active clinical development. Qsymia® (phentermine and topiramate extended release) is approved by FDA for chronic weight management. STENDRA® (avanafil) is approved for erectile dysfunction, or ED, by FDA and by the EC under the trade name SPEDRA in the EU. Tacrolimus is in active clinical development for the treatment of patients with pulmonary arterial hypertension, or PAH. Business Strategy Review In 2016, we initiated a business strategy review to maximize long-term stockholder value. ... More ...
Nasdaq Official Price
Nov. 19, 2018
Nov. 19, 2018